在心脏移植中管理抗体中介排斥
Alessio Aloisio1, Chiara Baldovini2, Olivier Thaunat3
1Heart Failure and Transplant Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy.
Expert opinion on biological therapy
|March 5, 2026
概括
心脏移植后的抗体介导排斥 (AMR) 是一个复杂的过程. 新的研究突出显示了AMR中的自然杀手 (NK) 细胞,这表明有针对性的疗法,但需要更多的临床数据来有效管理.
科学领域:
- 心脏病学 心脏病学
- 免疫学 免疫学 免疫学
- 移植科学 移植科学
背景情况:
- 抗体中介排斥 (AMR) 仍然是心脏移植的一个重大挑战,目前的临床管理缺乏强有力的证据.
- 最近的发现揭示了自然杀手 (NK) 细胞在AMR病变发生中发挥着核心作用,超出了传统的捐赠者特异性抗体 (DSA) 补充激活.
- 通过抗体依赖的细胞细胞毒性 (ADCC) 和通过"失踪自我"识别通过DSA负的内皮损伤,NK细胞有助于血管损伤.
研究的目的:
- 审查目前对AMR病理生理学的理解,强调NK细胞的作用.
- 讨论针对AMR中的NK细胞的新兴治疗策略.
- 突出需要改进AMR的诊断和分类方法.
主要方法:
- 文献综述和对AMR机制的最新研究的综合.
- 分析NK细胞,Fcγ受体和"缺失自我"识别在移植拒绝中的作用.
- 讨论潜在的治疗目标和临床试验要求.
主要成果:
- 在AMR中,NK细胞涉及DSA依赖和DSA独立的内皮损伤.
- 准NK细胞为AMR提供了一个有希望的治疗途径.
- 目前,稀少和异质的临床数据限制了采用新策略.
结论:
- 有效管理AMR需要一个精细的,心脏特异性的分类系统和验证的非侵入性生物标志物.
- 早期检测和监测使用生物标志物,如dd-cfDNA和NK-活动签名,对于临床试验至关重要.
- 推进NK细胞向疗法需要可重现的测试,多中心验证和标准化报告以获得临床采用.
相关概念视频
Kidney Transplant II: Surgical Procedure
592
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
592
Kidney Transplant III: Nursing Management
468
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
468
Cell-mediated Immune Responses
85.3K
Overview
85.3K
Tissue Transplantation
1.1K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.1K
Kidney Transplant I: Introduction
606
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
606
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.3K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K


